Kyverna Therapeutics, Inc.
Nasdaq: KYTX
- Raised $152 million (2023)
- 7 clinical trials, 3 active
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Mereo BioPharma Group plc
Nasdaq: MREO
- Raised $70 million (2020)
- Founded 2015
Niagen Bioscience, Inc.
Nasdaq: NAGE
- Raised $3.1 million (2022)
- 5 clinical trials, 2 active
- Founded 2008
PolyPid Ltd.
Nasdaq: PYPD
- Raised $27 million (2025)
- 7 clinical trials
Pulmatrix, Inc.
Nasdaq: PULM
- Raised $1 million (2026)
- 15 clinical trials
- Founded 2013
SELLAS Life Sciences Group, Inc.
Nasdaq: SLS
- Raised $18 million (2024)
- 9 clinical trials, 2 active
Voyager Therapeutics, Inc.
Nasdaq: VYGR
- Raised $20 million (2024)
- 7 clinical trials, 2 active
- Founded 2013
HeartBeam, Inc.
Nasdaq: BEAT
- Raised $200,000 (2019)
- 3 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2015
SentiAR, Inc.
- Raised $1.5 million (2026)
- FDA-cleared or approved devices
- Research grants: $4.4 million
- Founded 2017
GigaGen, Inc.
- Raised $36 million (2017)
- 3 clinical trials, 2 active
- Research grants: $16 million
MiNK Therapeutics, Inc.
Nasdaq: INKT
- 4 clinical trials, 1 active
- Research grants: $919,500
Rockwell Medical, Inc.
Nasdaq: RMTI
- Raised $22 million (2018)
- FDA-cleared or approved devices
Sensydia Corp
- Raised $7.8 million (2023)
- 4 clinical trials, 1 active
- Research grants: $5.2 million
- Founded 2015
Cti Biopharma Corp
- Raised $4.1 million (2010)
- 40 clinical trials
- Research grants: $225,000
Advanced Brain Monitoring, Inc.
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $24 million
Alumis Inc.
Nasdaq: ALMS
- Raised $40 million (2024)
- 13 clinical trials, 3 active
- Founded 2021
Amylyx Pharmaceuticals, Inc.
Nasdaq: AMLX
- Raised $30 million (2020)
- 13 clinical trials, 3 active
- Founded 2014
AN2 Therapeutics, Inc.
Nasdaq: ANTX
- Raised $40 million (2026)
- 6 clinical trials
Avm Biotechnology, LLC
- Raised $4.4 million (2021)
- 3 clinical trials, 2 active
- Research grants: $11 million
- Founded 2008
Chemomab Therapeutics Ltd.
Nasdaq: CMMB
- Raised $10 million (2024)
- 6 clinical trials
Eledon Pharmaceuticals, Inc.
Nasdaq: ELDN
- Raised $50 million (2024)
- 6 clinical trials, 3 active
Flint Rehabilitation Devices, LLC
- 6 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $33 million
ImageneBio, Inc.
Nasdaq: IMA
- Raised $43 million (2023)
- 6 clinical trials
Inherent Biosciences, Inc.
- Raised $1.5 million (2023)
- 1 clinical trial, 1 active
- Research grants: $5.5 million
- Founded 2019
Insulet Corp
Nasdaq: PODD
- 24 clinical trials, 6 active
- FDA-cleared or approved devices
iVeena Delivery Systems, Inc.
- Raised $2.1 million (2020)
- 3 clinical trials, 2 active
- Research grants: $12 million
- Founded 2014
Nasus Pharma Ltd
NYSE: NSRX
- Raised $15 million (2026)
- 6 clinical trials, 2 active
Olema Pharmaceuticals, Inc.
Nasdaq: OLMA
- Raised $250 million (2024)
- 6 clinical trials, 5 active
BlueWillow Biologics, Inc.
- Raised $850,000 (2024)
- 2 clinical trials
- Research grants: $19 million
- Founded 2006
HemoSonics, LLC
- Raised $15 million (2017)
- 26 clinical trials, 2 active
- Research grants: $7.8 million
Sonalasense, Inc.
- Raised $9.8 million (2023)
- 2 clinical trials
- Research grants: $7.5 million
- Founded 2019
Sonara Health, Inc.
- Raised $4.7 million (2025)
- 2 clinical trials, 1 active
- Research grants: $4.7 million
- Founded 2020
Great Lakes Neurotechnologies Inc.
- 19 clinical trials
- FDA-cleared or approved devices
- Research grants: $24 million
Infinite Biomedical Technologies, LLC
- 8 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $58 million
Prelude Therapeutics Inc
Nasdaq: PRLD
- Raised $50 million (2020)
- 12 clinical trials, 1 active
- Founded 2016
2seventy bio, Inc.
- Raised $170 million (2022)
- 2 clinical trials, 1 active
- 1 FDA-registered drug site
- Founded 2021
Lannett Co Inc
- Raised $28 million (2021)
- 4 clinical trials, 1 active
- 1 FDA-registered drug site
Medline Industries, LP
- 39 clinical trials
- FDA-cleared or approved devices
- 5 FDA-registered drug sites
UNITED THERAPEUTICS Corp
Nasdaq: UTHR
- 86 clinical trials, 10 active
- 4 FDA-registered drug sites
Akston Biosciences Corp
- Raised $5.2 million (2022)
- Research grants: $8.3 million
AbCellera Biologics Inc.
Nasdaq: ABCL
- Raised $75 million (2020)
- 8 clinical trials, 2 active
- Founded 2012
Aktis Oncology, Inc.
Nasdaq: AKTS
- Raised $175 million (2024)
- 2 clinical trials, 2 active
- Founded 2020
Apollomics Inc.
Nasdaq: APLM
- 5 clinical trials, 1 active
- Research grants: $320,000
Arbutus Biopharma Corp
Nasdaq: ABUS
- Raised $15 million (2021)
- 12 clinical trials, 1 active
- Founded 2005
Benitec Biopharma Inc.
Nasdaq: BNTC
- Raised $40 million (2024)
- 2 clinical trials, 1 active
- Founded 2019
BlossomHill Therapeutics, Inc.
Nasdaq: BLSM
- Raised $84 million (2025)
- 2 clinical trials, 2 active
- Founded 2020
Cue Biopharma, Inc.
Nasdaq: CUE
- Raised $30 million (2026)
- 2 clinical trials
- Founded 2014
Exai Bio Inc.
- Raised $71 million (2022)
- 1 clinical trial, 1 active
- Research grants: $3.3 million
- Founded 2021
Hinge Bio, Inc.
- Raised $31 million (2025)
- 2 clinical trials, 2 active
- Research grants: $449,366
- Founded 2015
Kalaris Therapeutics, Inc.
Nasdaq: KLRS
- Raised $121 million (2019)
- 11 clinical trials
- Founded 2018
Published company profiles only; counts update daily. Data licences